| Primary |
| Computerised Tomogram |
42.6% |
| Product Used For Unknown Indication |
13.0% |
| Prophylaxis |
11.2% |
| Premedication |
6.0% |
| Arteriogram Coronary |
5.7% |
| Hypertension |
3.9% |
| Urogram |
2.4% |
| Angiogram Pulmonary |
2.1% |
| Catheterisation Cardiac |
2.1% |
| Angiogram |
1.8% |
| Computerised Tomogram Abdomen |
1.2% |
| Insomnia |
1.2% |
| Arterial Therapeutic Procedure |
0.9% |
| Chronic Obstructive Pulmonary Disease |
0.9% |
| Computerised Tomogram Head |
0.9% |
| Computerised Tomogram Thorax |
0.9% |
| Percutaneous Coronary Intervention |
0.9% |
| Scan With Contrast |
0.9% |
| Abdomen Scan |
0.6% |
| Imaging Procedure |
0.6% |
|
| Renal Failure Acute |
16.7% |
| Urticaria |
13.8% |
| Nephropathy Toxic |
10.9% |
| Anaphylactic Shock |
8.0% |
| Rash |
6.3% |
| Throat Irritation |
6.3% |
| Hypersensitivity |
4.6% |
| Vomiting |
4.6% |
| Renal Failure Chronic |
4.0% |
| Anaphylactic Reaction |
3.4% |
| Sneezing |
3.4% |
| Throat Tightness |
3.4% |
| Pruritus |
2.9% |
| Rash Generalised |
2.3% |
| Shock |
1.7% |
| Syncope |
1.7% |
| Unresponsive To Stimuli |
1.7% |
| Wheezing |
1.7% |
| Cardiac Arrest |
1.1% |
| Cardio-respiratory Arrest |
1.1% |
|
| Secondary |
| Computerised Tomogram |
31.6% |
| Premedication |
26.3% |
| Arteriogram Coronary |
10.5% |
| Percutaneous Coronary Intervention |
10.5% |
| Angiogram Peripheral |
5.3% |
| Angiogram Pulmonary |
5.3% |
| Local Anaesthesia |
5.3% |
| Product Used For Unknown Indication |
5.3% |
|
| Rash |
20.0% |
| Acute Generalised Exanthematous Pustulosis |
10.0% |
| Anaphylactic Reaction |
10.0% |
| Nephropathy Toxic |
10.0% |
| Paraesthesia |
10.0% |
| Renal Failure |
10.0% |
| Septic Shock |
10.0% |
| Stupor |
10.0% |
| Vomiting |
10.0% |
|
| Concomitant |
| Muscle Spasms |
14.3% |
| Prophylaxis |
14.3% |
| Angiogram |
9.5% |
| Depression |
9.5% |
| Pain In Extremity |
9.5% |
| Anxiety |
4.8% |
| Fatigue |
4.8% |
| Formication |
4.8% |
| Insomnia |
4.8% |
| Medical Diet |
4.8% |
| Multiple Sclerosis |
4.8% |
| Neck Pain |
4.8% |
| Product Used For Unknown Indication |
4.8% |
| Urinary Incontinence |
4.8% |
|
|
